Skip to main content
Edwards Lifesciences10-Q: Acquisition completed

Edwards Lifesciences acquired Autus Valve Technologies for $128.9 million plus contingent milestones

Source: Autobound Signal API · 68 signals tracked for Edwards Lifesciences · updated

Get Edwards Lifesciences' live signals in Claude or ChatGPT, or by API

AskWhat changed at Edwards Lifesciences this week? Use Autobound signals for edwards.com.

What happened

Edwards Lifesciences acquired Autus Valve Technologies, Inc. in February 2026 for total consideration of $128.9 million, with contingent consideration of up to $132.5 million payable upon achieving certain regulatory and sales milestones.

Source

SEC EDGARAug 4, 2026

Quarterly report (Form 10-Q)

Edwards Lifesciences 10-Q for Quarter ended Jun 30, 2026

Filing excerpt

In February 2026, we acquired Autus Valve Technologies, Inc. (“Autus”) for total consideration of $128.9 million with contingent consideration of up to $132.5 million payable based on the achievement of certain regulatory and sales milestones.

sec.gov/Archives/edgar/data/1099800/000109980026000043/ew-20260630.htmRead the full source

Other signals in this filing (3)

Extracted by Autobound

From the Signal API record
Signal
10-Q: Acquisition completed

What this signalsIntegration work after a deal often opens needs for new systems and services.

Period
Quarter ended Jun 30, 2026
Fiscal year end
06/30
Filed
Aug 4, 2026

More 10-Q signals at other companies

The full record

From the Signal API record

Numbers

Dollar figure
$129M (total consideration for the acquisition of Autus Valve Technologies, Inc.)

Details

CIK
1099800
Accession number
0001099800-26-000043
Timeframe
Current year
Quarter
Q2
Filing year
2026
Period end date
Jun 30, 2026
Why it matters
Active integration needs
Signal category
Strategic

Extraction

Confidence
High
Relevance
85%
Sentiment
Positive
Detected
Nov 9, 2026
signal_type
sec-10q
signal_subtype
acquisitionCompleted

Use this data

Get every 10-Q signal for Edwards Lifesciences and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Edwards Lifesciences this week?”

  2. Send it to your own tools

    The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/38b9d41a-e9e7-488c-9bc6-8d7f84c1d3a9 returns this record as JSON. POST /v1/companies/enrich returns every signal for edwards.com.

{
  "signal_id": "38b9d41a-e9e7-488c-9bc6-8d7f84c1d3a9",
  "signal_type": "sec-10q",
  "signal_subtype": "acquisitionCompleted",
  "detected_at": "2026-11-09T06:32:59.363+00:00",
  "company": {
    "name": "Edwards Lifesciences",
    "domain": "edwards.com"
  },
  "data": {
    "detail": "Edwards Lifesciences acquired Autus Valve Technologies, Inc. in February 2026 for total consideration of $128.9 million, with contingent consideration of up to $132.5 million payable upon achieving certain regulatory and sales milestones. This integration may create opportunities for post-merger systems integration, clinical development software, and quality management solutions.",
    "metrics": {
      "timeframe": "current_year",
      "dollar_context": "total consideration for the acquisition of Autus Valve Technologies, Inc.",
      "dollar_millions": 128.9
    },
    "quarter": "Q2",
    "summary": "Edwards Lifesciences acquired Autus Valve Technologies for $128.9 million plus contingent milestones",
    "excerpts": "In February 2026, we acquired Autus Valve Technologies, Inc. (“Autus”) for total consideration of $128.9 million with contingent consideration of up to $132.5 million payable based on the achievement of certain regulatory and sales milestones.",
    "relevance": 0.85,
    "sentiment": "positive",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1099800/000109980026000043/ew-20260630.htm",
    "filing_date": "2026-08-04",
    "filing_year": 2026,
    "fiscal_year": 2026,
    "fiscal_year_end": "06/30",
    "period_end_date": "2026-06-30",
    "sales_relevance": "Active integration needs",
    "signal_category": "strategic"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.